Muscle Wasting Disorders Market Report 2026
Download Free Sample Buy Now
Muscle Wasting Disorders Market Global Report 2026 Market Report Infographic Image
Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Muscle Wasting Disorders Market Report 2026

Global Outlook – By Treatment Type (Medications, Physical Therapy, Nutritional Therapy, Surgery, Gene Therapy, Other Treatment Types), By Disorder Type (Muscular Dystrophy, Amyotrophic Lateral Sclerosis (ALS), Other Disorder Types), By End-User (Hospitals, Rehab Centers, Specialty Clinics, Other End-Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Muscle Wasting Disorders Market Overview

• Muscle Wasting Disorders market size has reached to $17.49 billion in 2025

• Expected to grow to $33.5 billion in 2030 at a compound annual growth rate (CAGR) of 13.8%

• Growth Driver: Sedentary Lifestyle Trends Fueling Growth In The Muscle Wasting Disorders Market

• Market Trend: Innovative Advancements In The Muscle Wasting Disorders Market

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Muscle Wasting Disorders Market?

Muscle wasting disorders, or muscle atrophy or muscle wasting, refer to a condition characterized by a diverse group of conditions that cause the progressive loss of muscle mass and strength. This can occur as a result of various factors, including disuse, aging, malnutrition, neurodegenerative diseases, and certain medical conditions.

The main treatments of muscle wasting disorders are medications, physical therapy, nutritional therapy, surgery, gene therapy, and others. Muscle wasting disorder medications refer to drugs that are used to treat conditions such as sarcopenia, cachexia, and muscular dystrophy. These medications aim to increase muscle mass and improve muscle function. They are used for the treatment of muscular dystrophy, amyotrophic lateral sclerosis (ALS), and others by hospitals, rehab centers, specialty clinics, and other end-users.

Muscle Wasting Disorders Market Global Report 2026 Market Report bar graph

What Is The Muscle Wasting Disorders Market Size and Share 2026?

The muscle wasting disorders market size has grown rapidly in recent years. It will grow from $17.49 billion in 2025 to $19.96 billion in 2026 at a compound annual growth rate (CAGR) of 14.2%. The growth in the historic period can be attributed to prevalence of muscular dystrophy and als, increased use of physical therapy, rise in nutritional supplement usage, early adoption of anti-inflammatory treatments, growth in hospital-based rehabilitation services.

What Is The Muscle Wasting Disorders Market Growth Forecast?

The muscle wasting disorders market size is expected to see rapid growth in the next few years. It will grow to $33.5 billion in 2030 at a compound annual growth rate (CAGR) of 13.8%. The growth in the forecast period can be attributed to advancements in gene therapy technologies, growing investment in regenerative medicine, expansion of specialized rehab centers, increasing demand for personalized treatment plans, rising focus on nutritional interventions. Major trends in the forecast period include rising adoption of gene therapy for muscle regeneration, growing use of nutritional and protein supplementation, increased demand for physical rehabilitation programs, expansion of targeted therapies for muscular dystrophy, rising utilization of hormonal and anti-inflammatory medications.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Muscle Wasting Disorders Market Segmentation

1) By Treatment Type: Medications, Physical Therapy, Nutritional Therapy, Surgery, Gene Therapy, Other Treatment Types

2) By Disorder Type: Muscular Dystrophy, Amyotrophic Lateral Sclerosis (ALS), Other Disorder Types

3) By End-User: Hospitals, Rehab Centers, Specialty Clinics, Other End-Users

Subsegments:

1) By Medications: Anabolic Steroids, Hormonal Treatments, Anti-Inflammatory Drugs, Immunomodulatory Agents

2) By Physical Therapy: Resistance Training, Stretching Exercises, Aerobic Conditioning, Rehabilitation Programs

3) By Nutritional Therapy: Protein Supplements, Nutritional Counseling, Dietary Modifications, Micronutrient Supplements

4) By Surgery: Surgical Interventions For Muscle Repair, Orthopedic Surgeries, Procedures For Underlying Conditions

5) By Gene Therapy: Gene Replacement Therapy, CRISPR-Based Approaches, RNA Interference Techniques

6) By Other Treatment Types: Complementary Therapies, Psychological Support, Assistive Devices

What Is The Driver Of The Muscle Wasting Disorders Market?

Rising adherence to a sedentary lifestyle is expected to propel the growth of the muscle wasting disorders market going forward. A sedentary lifestyle refers to a lifestyle in which an individual is physically inactive and engages in little or no physical movement or exercise. Sedentary behavior can negatively impact muscle function, leading to a decline in muscle strength and endurance, contributing to muscle wasting disorders, and making it more difficult for individuals to maintain their muscle mass and function. For instance, in March 2025, according to the NHS England, a UK-based executive non-departmental public body, more than one-quarter of adults were classified as inactive, while almost one-third of children and young people (30.2 percent) in 2023 engaged in less than 30 minutes of daily physical activity. Therefore, rising adherence to a sedentary lifestyle is driving the growth of the muscle wasting disorders industry.

Key Players In The Global Muscle Wasting Disorders Market

Major companies operating in the muscle wasting disorders market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Roche Holding AG, Novartis AG, Sanofi, GlaxoSmithKline (GSK), Regeneron Pharmaceuticals, Acceleron Pharma Inc., Biogen Inc., Santhera Pharmaceuticals Holding AG, Mitsubishi Tanabe Pharma, Sarepta Therapeutics Inc., PTC Therapeutics Inc., Ionis Pharmaceuticals Inc., Cytokinetics Incorporated, Scholar Rock, Akashi Therapeutics, aTyr Pharma, MyoTherix Inc., Pephexia Therapeutics, Biophytis SA, TNF Pharmaceuticals Inc., Rejuvenate Biomed, Edgewise Therapeutics

Global Muscle Wasting Disorders Market Trends and Insights

Major companies operating in the muscle wasting disorders market are developing innovative products, such as novel gene therapy, to better serve patients with muscle wasting disorders. Novel gene therapy refers to a medical technology that aims to produce a therapeutic effect through the manipulation of gene expression or altering the biological properties of living cells. For instance, in June 2023, Sarepta Therapeutics, a US-based biotechnology company, introduced Elevidys, which is the first gene therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Duchenne muscular dystrophy (DMD) in pediatric patients between the ages of 4 and 5 years old. Elevidys is a recombinant gene therapy designed to deliver into the body a gene that leads to a shortened protein that contains selected domains of the dystrophin protein of normal muscle cells. The product is administered as a single intravenous infusion.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Muscle Wasting Disorders Market?

In September 2023, Biogen Inc., a US-based biotechnology company, acquired Reata Pharmaceuticals Inc. for $7.3 billion. With the acquisition, Biogen is expected to bolster Biogen's rare disease portfolio with the addition of Friedreich's ataxia, which is a genetic, progressive, life-shortening, debilitating, and degenerative disease that affects the nervous system and muscles. Reata Pharmaceuticals Inc. is a US-based pharmaceutical company focused on developing therapeutics for neuromuscular disorders and muscle wasting disorders.

Regional Outlook

North America was the largest region in the muscle wasting disorder market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Muscle Wasting Disorders Market?

The muscle wasting disorders market consists of revenues earned by entities by providing services such as diagnostic services, medical services, support services and community services. The market value includes the value of related goods sold by the service provider or included within the service offering. The muscle wasting disorders market also includes sales of anabolic steroids, growth hormone, enobosarm and bimagrumab. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Muscle Wasting Disorders Market Report 2026?

The muscle wasting disorders market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the muscle wasting disorders industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Muscle Wasting Disorders Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $19.96 billion
Revenue Forecast In 2035 $33.5 billion
Growth Rate CAGR of 14.2% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Treatment Type, Disorder Type, End-User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Pfizer Inc., F. Hoffmann-La Roche Ltd., Roche Holding AG, Novartis AG, Sanofi, GlaxoSmithKline (GSK), Regeneron Pharmaceuticals, Acceleron Pharma Inc., Biogen Inc., Santhera Pharmaceuticals Holding AG, Mitsubishi Tanabe Pharma, Sarepta Therapeutics Inc., PTC Therapeutics Inc., Ionis Pharmaceuticals Inc., Cytokinetics Incorporated, Scholar Rock, Akashi Therapeutics, aTyr Pharma, MyoTherix Inc., Pephexia Therapeutics, Biophytis SA, TNF Pharmaceuticals Inc., Rejuvenate Biomed, Edgewise Therapeutics
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Muscle Wasting Disorders Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Muscle Wasting Disorders Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Muscle Wasting Disorders Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Muscle Wasting Disorders Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Rising Adoption Of Gene Therapy For Muscle Regeneration

4.2.2 Growing Use Of Nutritional And Protein Supplementation

4.2.3 Increased Demand For Physical Rehabilitation Programs

4.2.4 Expansion Of Targeted Therapies For Muscular Dystrophy

4.2.5 Rising Utilization Of Hormonal And Anti-Inflammatory Medications

5. Muscle Wasting Disorders Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Rehab Centers

5.3 Specialty Clinics

5.4 Homecare Providers

5.5 Physiotherapy Centers

6. Muscle Wasting Disorders Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Muscle Wasting Disorders Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Muscle Wasting Disorders PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Muscle Wasting Disorders Market Size, Comparisons And Growth Rate Analysis

7.3. Global Muscle Wasting Disorders Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Muscle Wasting Disorders Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Muscle Wasting Disorders Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Muscle Wasting Disorders Market Segmentation

9.1. Global Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Medications, Physical Therapy, Nutritional Therapy, Surgery, Gene Therapy, Other Treatment Types

9.2. Global Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Muscular Dystrophy, Amyotrophic Lateral Sclerosis (ALS), Other Disorder Types

9.3. Global Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Rehab Centers, Specialty Clinics, Other End-Users

9.4. Global Muscle Wasting Disorders Market, Sub-Segmentation Of Medications, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Anabolic Steroids, Hormonal Treatments, Anti-Inflammatory Drugs, Immunomodulatory Agents

9.5. Global Muscle Wasting Disorders Market, Sub-Segmentation Of Physical Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Resistance Training, Stretching Exercises, Aerobic Conditioning, Rehabilitation Programs

9.6. Global Muscle Wasting Disorders Market, Sub-Segmentation Of Nutritional Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Protein Supplements, Nutritional Counseling, Dietary Modifications, Micronutrient Supplements

9.7. Global Muscle Wasting Disorders Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Surgical Interventions for Muscle Repair, Orthopedic Surgeries, Procedures for Underlying Conditions

9.8. Global Muscle Wasting Disorders Market, Sub-Segmentation Of Gene Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Gene Replacement Therapy, CRISPR-Based Approaches, RNA Interference Techniques

9.9. Global Muscle Wasting Disorders Market, Sub-Segmentation Of Other Treatment Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Complementary Therapies, Psychological Support, Assistive Devices

10. Muscle Wasting Disorders Market Regional And Country Analysis

10.1. Global Muscle Wasting Disorders Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Muscle Wasting Disorders Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Muscle Wasting Disorders Market

11.1. Asia-Pacific Muscle Wasting Disorders Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Muscle Wasting Disorders Market, Segmentation By Treatment Type, Segmentation By Disorder Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Muscle Wasting Disorders Market

12.1. China Muscle Wasting Disorders Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Muscle Wasting Disorders Market, Segmentation By Treatment Type, Segmentation By Disorder Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Muscle Wasting Disorders Market

13.1. India Muscle Wasting Disorders Market, Segmentation By Treatment Type, Segmentation By Disorder Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Muscle Wasting Disorders Market

14.1. Japan Muscle Wasting Disorders Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Muscle Wasting Disorders Market, Segmentation By Treatment Type, Segmentation By Disorder Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Muscle Wasting Disorders Market

15.1. Australia Muscle Wasting Disorders Market, Segmentation By Treatment Type, Segmentation By Disorder Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Muscle Wasting Disorders Market

16.1. Indonesia Muscle Wasting Disorders Market, Segmentation By Treatment Type, Segmentation By Disorder Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Muscle Wasting Disorders Market

17.1. South Korea Muscle Wasting Disorders Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Muscle Wasting Disorders Market, Segmentation By Treatment Type, Segmentation By Disorder Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Muscle Wasting Disorders Market

18.1. Taiwan Muscle Wasting Disorders Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Muscle Wasting Disorders Market, Segmentation By Treatment Type, Segmentation By Disorder Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Muscle Wasting Disorders Market

19.1. South East Asia Muscle Wasting Disorders Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Muscle Wasting Disorders Market, Segmentation By Treatment Type, Segmentation By Disorder Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Muscle Wasting Disorders Market

20.1. Western Europe Muscle Wasting Disorders Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Muscle Wasting Disorders Market, Segmentation By Treatment Type, Segmentation By Disorder Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Muscle Wasting Disorders Market

21.1. UK Muscle Wasting Disorders Market, Segmentation By Treatment Type, Segmentation By Disorder Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Muscle Wasting Disorders Market

22.1. Germany Muscle Wasting Disorders Market, Segmentation By Treatment Type, Segmentation By Disorder Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Muscle Wasting Disorders Market

23.1. France Muscle Wasting Disorders Market, Segmentation By Treatment Type, Segmentation By Disorder Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Muscle Wasting Disorders Market

24.1. Italy Muscle Wasting Disorders Market, Segmentation By Treatment Type, Segmentation By Disorder Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Muscle Wasting Disorders Market

25.1. Spain Muscle Wasting Disorders Market, Segmentation By Treatment Type, Segmentation By Disorder Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Muscle Wasting Disorders Market

26.1. Eastern Europe Muscle Wasting Disorders Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Muscle Wasting Disorders Market, Segmentation By Treatment Type, Segmentation By Disorder Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Muscle Wasting Disorders Market

27.1. Russia Muscle Wasting Disorders Market, Segmentation By Treatment Type, Segmentation By Disorder Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Muscle Wasting Disorders Market

28.1. North America Muscle Wasting Disorders Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Muscle Wasting Disorders Market, Segmentation By Treatment Type, Segmentation By Disorder Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Muscle Wasting Disorders Market

29.1. USA Muscle Wasting Disorders Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Muscle Wasting Disorders Market, Segmentation By Treatment Type, Segmentation By Disorder Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Muscle Wasting Disorders Market

30.1. Canada Muscle Wasting Disorders Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Muscle Wasting Disorders Market, Segmentation By Treatment Type, Segmentation By Disorder Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Muscle Wasting Disorders Market

31.1. South America Muscle Wasting Disorders Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Muscle Wasting Disorders Market, Segmentation By Treatment Type, Segmentation By Disorder Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Muscle Wasting Disorders Market

32.1. Brazil Muscle Wasting Disorders Market, Segmentation By Treatment Type, Segmentation By Disorder Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Muscle Wasting Disorders Market

33.1. Middle East Muscle Wasting Disorders Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Muscle Wasting Disorders Market, Segmentation By Treatment Type, Segmentation By Disorder Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Muscle Wasting Disorders Market

34.1. Africa Muscle Wasting Disorders Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Muscle Wasting Disorders Market, Segmentation By Treatment Type, Segmentation By Disorder Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Muscle Wasting Disorders Market Regulatory and Investment Landscape

36. Muscle Wasting Disorders Market Competitive Landscape And Company Profiles

36.1. Muscle Wasting Disorders Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Muscle Wasting Disorders Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Muscle Wasting Disorders Market Company Profiles

36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Sanofi Overview, Products and Services, Strategy and Financial Analysis

37. Muscle Wasting Disorders Market Other Major And Innovative Companies

GlaxoSmithKline (GSK), Regeneron Pharmaceuticals, Acceleron Pharma Inc., Biogen Inc., Santhera Pharmaceuticals Holding AG, Mitsubishi Tanabe Pharma, Sarepta Therapeutics Inc., PTC Therapeutics Inc., Ionis Pharmaceuticals Inc., Cytokinetics Incorporated, Scholar Rock, Akashi Therapeutics, aTyr Pharma, MyoTherix Inc., Pephexia Therapeutics

38. Global Muscle Wasting Disorders Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Muscle Wasting Disorders Market

40. Muscle Wasting Disorders Market High Potential Countries, Segments and Strategies

40.1 Muscle Wasting Disorders Market In 2030 - Countries Offering Most New Opportunities

40.2 Muscle Wasting Disorders Market In 2030 - Segments Offering Most New Opportunities

40.3 Muscle Wasting Disorders Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Muscle Wasting Disorders Market, Overview Of Key Products - Product Examples
  • Table 2: Global Muscle Wasting Disorders Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Muscle Wasting Disorders Market, Supply Chain Analysis
  • Table 4: Global Muscle Wasting Disorders Market, Major Raw Material Providers
  • Table 5: Global Muscle Wasting Disorders Market, Major Resource Providers
  • Table 6: Global Muscle Wasting Disorders Market, Major Manufacturers (Suppliers)
  • Table 7: Global Muscle Wasting Disorders Market, Major Distributors And Channel Partners
  • Table 8: Global Muscle Wasting Disorders Market, Key Technologies & Future Trends
  • Table 9: Global Muscle Wasting Disorders Market, Major Trends
  • Table 10: Global Muscle Wasting Disorders Market, Major End Users
  • Table 11: Global Muscle Wasting Disorders Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Muscle Wasting Disorders Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Muscle Wasting Disorders Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Muscle Wasting Disorders Market - TAM, US$ Billion, 2025
  • Table 15: Global Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Muscle Wasting Disorders Market, Sub-Segmentation Of Medications, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Muscle Wasting Disorders Market, Sub-Segmentation Of Physical Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Muscle Wasting Disorders Market, Sub-Segmentation Of Nutritional Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Muscle Wasting Disorders Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Muscle Wasting Disorders Market, Sub-Segmentation Of Gene Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Muscle Wasting Disorders Market, Sub-Segmentation Of Other Treatment Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Global Muscle Wasting Disorders Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Global Muscle Wasting Disorders Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Asia-Pacific, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: Asia-Pacific, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: Asia-Pacific, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: China, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: China, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: China, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: India, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: India, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: India, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Japan, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Japan, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Japan, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Australia, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Australia, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Australia, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Indonesia, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: Indonesia, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: Indonesia, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: South Korea, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: South Korea, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: South Korea, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Taiwan, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: Taiwan, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: Taiwan, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: South East Asia, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: South East Asia, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: South East Asia, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Western Europe, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: Western Europe, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: Western Europe, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: UK, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: UK, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: UK, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Germany, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Germany, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Germany, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: France, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: France, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: France, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Italy, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Italy, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Italy, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Spain, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Spain, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Spain, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Eastern Europe, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Eastern Europe, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Eastern Europe, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Russia, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: Russia, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: Russia, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: North America, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: North America, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: North America, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: USA, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: USA, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: USA, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: Canada, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: Canada, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: Canada, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: South America, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: South America, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: South America, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Brazil, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Brazil, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Brazil, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Middle East, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Middle East, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Middle East, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Africa, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Africa, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 97: Africa, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 98: Global Muscle Wasting Disorders Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 99: Global Muscle Wasting Disorders Market - Company Scoring Matrix
  • Table 100: Pfizer Inc. Financial Performance
  • Table 101: F. Hoffmann-La Roche Ltd. Financial Performance
  • Table 102: Roche Holding AG Financial Performance
  • Table 103: Novartis AG Financial Performance
  • Table 104: Sanofi Financial Performance
  • Table 105: Global Muscle Wasting Disorders Market, Competitive Benchmarking (In USD Billions)
  • Table 106: Global Muscle Wasting Disorders Market, Competitive Dashboard
  • Table 107: Global Muscle Wasting Disorders Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 108: Global, Muscle Wasting Disorders Market Size Gain ($ Billion), Segmentation By Treatment Type, 2025 – 2030
  • Table 109: Global, Muscle Wasting Disorders Market Size Gain ($ Billion), Segmentation By Disorder Type, 2025 – 2030
  • Table 110: Global, Muscle Wasting Disorders Market Size Gain ($ Billion), Segmentation By End-User, 2025 – 2030

List Of Figures

    Figure 1: Global Muscle Wasting Disorders Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Muscle Wasting Disorders Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Muscle Wasting Disorders Market, Supply Chain Analysis
  • Figure 4: Global Muscle Wasting Disorders Market, Major Raw Material Providers
  • Figure 5: Global Muscle Wasting Disorders Market, Major Resource Providers
  • Figure 6: Global Muscle Wasting Disorders Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Muscle Wasting Disorders Market, Major Distributors And Channel Partners
  • Figure 8: Global Muscle Wasting Disorders Market, Key Technologies & Future Trends
  • Figure 9: Global Muscle Wasting Disorders Market, Major Trends
  • Figure 10: Global Muscle Wasting Disorders Market, Major End Users
  • Figure 11: Global Muscle Wasting Disorders Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Muscle Wasting Disorders Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Muscle Wasting Disorders Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Muscle Wasting Disorders Market - TAM, US$ Billion, 2025
  • Figure 15: Global Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Muscle Wasting Disorders Market, Sub-Segmentation Of Medications, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Muscle Wasting Disorders Market, Sub-Segmentation Of Physical Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Muscle Wasting Disorders Market, Sub-Segmentation Of Nutritional Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Muscle Wasting Disorders Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Muscle Wasting Disorders Market, Sub-Segmentation Of Gene Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Muscle Wasting Disorders Market, Sub-Segmentation Of Other Treatment Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Global Muscle Wasting Disorders Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Global Muscle Wasting Disorders Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Asia-Pacific, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: Asia-Pacific, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: Asia-Pacific, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: China, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: China, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: China, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: India, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: India, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: India, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Japan, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Japan, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Japan, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Australia, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Australia, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Australia, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Indonesia, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: Indonesia, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: Indonesia, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: South Korea, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: South Korea, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: South Korea, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Taiwan, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: Taiwan, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: Taiwan, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: South East Asia, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: South East Asia, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: South East Asia, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Western Europe, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: Western Europe, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: Western Europe, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: UK, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: UK, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: UK, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Germany, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Germany, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Germany, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: France, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: France, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: France, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Italy, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Italy, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Italy, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Spain, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Spain, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Spain, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Eastern Europe, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Eastern Europe, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Eastern Europe, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Russia, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: Russia, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: Russia, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: North America, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: North America, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: North America, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: USA, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: USA, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: USA, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: Canada, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: Canada, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: Canada, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: South America, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: South America, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: South America, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Brazil, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Brazil, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Brazil, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Middle East, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Middle East, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Middle East, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Africa, Muscle Wasting Disorders Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Africa, Muscle Wasting Disorders Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 97: Africa, Muscle Wasting Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 98: Global Muscle Wasting Disorders Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 99: Global Muscle Wasting Disorders Market - Company Scoring Matrix
  • Figure 100: Pfizer Inc. Financial Performance
  • Figure 101: F. Hoffmann-La Roche Ltd. Financial Performance
  • Figure 102: Roche Holding AG Financial Performance
  • Figure 103: Novartis AG Financial Performance
  • Figure 104: Sanofi Financial Performance
  • Figure 105: Global Muscle Wasting Disorders Market, Competitive Benchmarking (In USD Billions)
  • Figure 106: Global Muscle Wasting Disorders Market, Competitive Dashboard
  • Figure 107: Global Muscle Wasting Disorders Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 108: Global, Muscle Wasting Disorders Market Size Gain ($ Billion), Segmentation By Treatment Type, 2025 – 2030
  • Figure 109: Global, Muscle Wasting Disorders Market Size Gain ($ Billion), Segmentation By Disorder Type, 2025 – 2030
  • Figure 110: Global, Muscle Wasting Disorders Market Size Gain ($ Billion), Segmentation By End-User, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

Read More About Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Read More About Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Read More About A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Read More About A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Read More About A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Musculoskeletal Disorders Drugs Global Market Report 2022 – By Type (Drugs For Rheumatoid Arthritis, Muscle Relaxants, Other Musculoskeletal Disorders Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmaci...

Musculoskeletal Disorders Drugs Global Market Report 2022 – By Type (Drugs For Rheumatoid Arthritis, Muscle Relaxants, Other Musculoskeletal Disorders Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmaci...

Inbound Logistics Market Report 2026 - Global Outlook – By Function (Transportation; Warehousing; Inventory Management; Procurement; Supplier Relationship Management), By Mode Of Transportation (Roadways; Railways; Airwa...

RF Signal Chain Components Market Report 2026 - Global Outlook – By Product ( Amplifiers, Voltage-Controlled Oscillators, Power Dividers, Mixers, Filters, Switches, Attenuators, Diplexers, Duplexers, Couplers ), By Mater...

Automotive Cloud Based Solutions Market Report 2026 - Global Outlook – By Service Model (Professional Services, Managed Services), By Deployment Type (Private Cloud, Public Cloud), By Vehicle Type (Passenger Vehicles, Co...

Endotracheal Tubes Market Report 2026 - Global Outlook – By Product (Regular Endotracheal Tube, Reinforced Endotracheal Tube, Preformed Endotracheal Tube, Double Lumen Endotracheal Tube), By Route Type (Orotracheal, Naso...

Frequently Asked Questions

The Muscle Wasting Disorders market was valued at $17.49 billion in 2025, increased to $19.96 billion in 2026, and is projected to reach $33.5 billion by 2030.

The global Muscle Wasting Disorders market is expected to grow at a CAGR of 13.8% from 2026 to 2035 to reach $33.5 billion by 2035.

Some Key Players in the Muscle Wasting Disorders market Include, Pfizer Inc., F. Hoffmann-La Roche Ltd., Roche Holding AG, Novartis AG, Sanofi, GlaxoSmithKline (GSK), Regeneron Pharmaceuticals, Acceleron Pharma Inc., Biogen Inc., Santhera Pharmaceutic

Major trend in this market includes: Innovative Advancements In The Muscle Wasting Disorders Market . For further insights on this market. request a sample here

North America was the largest region in the muscle wasting disorder market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the muscle wasting disorders market report are Asia-

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us